MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.89 -0.08 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

MeiraGTx Holdings (MGTX) Free Cash Flow (2017 - 2025)

MeiraGTx Holdings' (MGTX) quarterly Free Cash Flow came in at $46.4 million in Q4 2025, up 289.27% YoY from $11.9 million in Q4 2024, and up 461.47% on a QoQ basis from -$12.8 million in Q3 2025.

Analysis

MeiraGTx Holdings (MGTX) Free Cash Flow (2017 - 2025) Analysis & Trends

MeiraGTx Holdings (MGTX) has 9 years of Free Cash Flow data on file, last reported at $46.4 million in Q4 2025.

  • Quarterly Free Cash Flow rose 289.27% year-over-year to $46.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$50.2 million (up 54.15% YoY) and the FY2025 annual result came in at -$50.2 million, up 54.15% from the prior year.
  • Free Cash Flow grew to $46.4 million in Q4 2025, from -$12.8 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $46.4 million in Q4 2025 to a low of -$61.1 million in Q4 2022.
  • A 5-year average of -$22.1 million and a median of -$25.1 million in 2024 frame the typical range for Free Cash Flow.
  • Annual changes were most pronounced in 2022 — Free Cash Flow tumbled 1003.03% — and 2025, when it surged 289.27%.
  • Tracing MGTX's Free Cash Flow over 5 years: stood at -$5.5 million in 2021, then plunged by 1003.03% to -$61.1 million in 2022, then jumped by 73.26% to -$16.3 million in 2023, then sank by 49.89% to -$24.5 million in 2024, then surged by 289.27% to $46.4 million in 2025.
  • The last three Free Cash Flow figures came in at $46.4 million (Q4 2025), -$12.8 million (Q3 2025), and -$45.2 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -563.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -389.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 437.80 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 292.04 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 477.44 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -95.09 Mn
10 MeiraGTx Holdings 1.27 Bn 1.13 Bn 315.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 46.33 Mn
Sep 30, 2025 -12.84 Mn
Jun 30, 2025 -45.18 Mn
Mar 31, 2025 -38.54 Mn
Dec 31, 2024 -24.49 Mn
Sep 30, 2024 -25.75 Mn
Jun 30, 2024 -20.79 Mn
Mar 31, 2024 -38.42 Mn
Dec 31, 2023 -17.58 Mn
Sep 30, 2023 -27.98 Mn
Jun 30, 2023 -33.99 Mn
Mar 31, 2023 -46.00 Mn
Dec 31, 2022 -24.76 Mn
Sep 30, 2022 -30.74 Mn
Jun 30, 2022 -41.81 Mn
Mar 31, 2022 -20.76 Mn
Dec 31, 2021 -5.54 Mn
Sep 30, 2021 -29.09 Mn
Jun 30, 2021 -26.84 Mn
Mar 31, 2021 4.58 Mn